Skip to main content

Table 1 Histone acetylation and modulation of molecules in Wnt/β-catenin signaling

From: The interaction of canonical Wnt/β-catenin signaling with protein lysine acetylation

Histone modifier

Histone modification

Target gene

Effect on target genes

Target cells or models

References

GCN5

H3K9Ac

Wnt1

Activation

BMSCs

[59]

GCN5

H3K9Ac

Wnt10a

Activation

BMSCs

[59]

GCN5

H3K9Ac

Wnt6

Activation

BMSCs

[59]

GCN5

H3K9Ac

Wnt10b

Activation

BMSCs

[59]

HDAC1

unknown

β-catenin

Inhibition

MEFs

[60]

P300

H3K27Ac

FZD3

Activation

Alzheimer’s disease mouse model

[61]

SIRT6

H3K9Ac

FZD4

Inhibition

Hepatoblastoma cells

[62]

HDAC3

unknown

WIF-1

Inhibition

Fibroblasts

[63]

HDAC1

H3Ac

SFRP1

Inhibition

HCC cells

[64]

SIRT1

H3K9Ac

SFRP1

Inhibition

MEFs

[38]

SIRT1

H4K16Ac

SFRP1

Inhibition

MEFs

[38]

SIRT1

H3K9Ac

SFRP2

Inhibition

MEFs

[38]

SIRT1

H4K16Ac

SFRP2

Inhibition

MEFs

[38]

HDAC1

H3Ac

DKK1

Inhibition

Breast cancer cells

[66]

HDAC2

H3Ac

DKK1

Inhibition

Breast cancer cells

[66]

HDAC1

H4Ac

DKK1

Inhibition

Breast cancer cells

[66]

HDAC2

H4Ac

DKK1

Inhibition

Breast cancer cells

[66]

GCN5

H3K9Ac

DKK1

Activation

Periodontal ligament stem cells

[67]

GCN5

H3K14Ac

DKK1

Activation

Periodontal ligament stem cells

[67]

p300

H3Ac

DKK1

Activation

Breast cancer cells, HCC cells,

[68, 70]

CBP

H3Ac

DKK1

Activation

Breast cancer cells

[68]

  1. Ac: acetylation